These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 17006916
21. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A. Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041 [Abstract] [Full Text] [Related]
22. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Albillos A, Bañares R, González M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM. Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317 [Abstract] [Full Text] [Related]
23. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. Am J Gastroenterol; 2001 Dec; 96(12):3379-83. PubMed ID: 11774952 [Abstract] [Full Text] [Related]
24. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Colombato L. J Clin Gastroenterol; 2007 Dec; 41 Suppl 3():S344-51. PubMed ID: 17975487 [Abstract] [Full Text] [Related]
25. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Villanueva C, Planella M, Aracil C, López-Balaguer JM, González B, Miñana J, Balanzó J. Am J Gastroenterol; 2005 Mar; 100(3):624-30. PubMed ID: 15743361 [Abstract] [Full Text] [Related]
26. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients. Vidal V, Joly L, Perreault P, Bouchard L, Lafortune M, Pomier-Layrargues G. Cardiovasc Intervent Radiol; 2006 Mar; 29(2):216-9. PubMed ID: 16284702 [Abstract] [Full Text] [Related]
27. Current endoscopic therapy of variceal bleeding. Villanueva C, Colomo A, Aracil C, Guarner C. Best Pract Res Clin Gastroenterol; 2008 Mar; 22(2):261-78. PubMed ID: 18346683 [Abstract] [Full Text] [Related]
30. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, Lin CK, Chan HH, Pan HB. Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241 [Abstract] [Full Text] [Related]
32. Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis. Dittrich S, de Mattos AA, Becker M, Gonçaves DM, Cheinquer H. Hepatogastroenterology; 2003 Aug; 50(54):2052-6. PubMed ID: 14700005 [Abstract] [Full Text] [Related]
33. Secondary prophylaxis for esophageal variceal bleeding. Albillos A, Tejedor M. Clin Liver Dis; 2014 May; 18(2):359-70. PubMed ID: 24679500 [Abstract] [Full Text] [Related]
36. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287 [Abstract] [Full Text] [Related]
39. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage. Tsai YT, Lee FY, Lin HC, Lee SD, Hsia HC, Lin WJ, Wang SS, Lay CS, Lai KH, Lo KJ. Hepatology; 1991 Mar; 13(3):407-12. PubMed ID: 1999311 [Abstract] [Full Text] [Related]